| 000 | 00995 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250514071601.0 | ||
| 264 | 0 | _c20030724 | |
| 008 | 200307s 0 0 eng d | ||
| 022 | _a1521-6616 | ||
| 024 | 7 |
_a10.1016/s1521-6616(03)00034-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHolers, V Michael | |
| 245 | 0 | 0 |
_aThe complement system as a therapeutic target in autoimmunity. _h[electronic resource] |
| 260 |
_bClinical immunology (Orlando, Fla.) _cJun 2003 |
||
| 300 |
_a140-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAutoimmune Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aComplement Activation _xdrug effects |
| 650 | 0 | 4 |
_aComplement Inactivator Proteins _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aReceptors, Complement _xantagonists & inhibitors |
| 773 | 0 |
_tClinical immunology (Orlando, Fla.) _gvol. 107 _gno. 3 _gp. 140-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1521-6616(03)00034-2 _zAvailable from publisher's website |
| 999 |
_c12588867 _d12588867 |
||